The DOI matches its Crossref record; 182 of the 184 references it cites were found in a registry or an index.
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Abstract
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A member of its family, the JAK2/STAT3 signal pathway, is involved in neuronal death and nervous reorganization in ischemic encephalopathy [62].”
Citations
Cites
1 retracted
Ling, L., Zhang, S., Zhi, L.-D., Li, H., Wen, Q.-K., Li, G., & Zhang, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.042 · Cited by 31
RetractedSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Epidemiology of Parkinson’s disease
Tysnes, O., & Storstein, A. M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,437
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Flagged first, then by citations
2 of the 184 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Seif, 2017, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun. Sign., 15, 1
- Oshea, 2015, The JAK-STAT pathway: impact on human disease and therapeutic intervention*, Annu. Rev. Med., 66, 311, 10.1146/annurev-med-051113-024537 · DOI
- Yan, 2018, Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases, Clin. Immunol., 189, 4, 10.1016/j.clim.2016.09.014 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 1,000
Application of Baricitinib in Dermatology
Zhang, J.-Y., Qi, F., Dong, J., Tan, Y.-Q., Gao, L., & Liu, F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s356316 · Cited by 34
Singh, R., Kisku, A., Kungumaraj, H. J., Nagaraj, V., Pal, A., Kumar, S., & Sulakhiya, K. (2023) · Biomedicines · doi:10.3390/biomedicines11010115 · Cited by 45
Hydrolyzable Tannins in the Management of Th1, Th2 and Th17 Inflammatory-Related Diseases
Piazza, S., Fumagalli, M., Martinelli, G., Pozzoli, C., Maranta, N., Angarano, M., Sangiovanni, E., & Dell’Agli, M. (2022) · Molecules · doi:10.3390/molecules27217593 · Cited by 44
Kopalli, S. R., Prakash, A. V., & Koppula, S. (2022) · Molecules · doi:10.3390/molecules27144660 · Cited by 45
A New Strategy for the Regulation of Neuroinflammation: Exosomes Derived from Mesenchymal Stem Cells
Ge, Y., Wu, J., Zhang, L., Huang, N., & Luo, Y. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01460-x · Cited by 48
Advances in research on the anti-tumor mechanism of Astragalus polysaccharides
Yang, Q., Meng, D., Zhang, Q., & Wang, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1334915 · Cited by 44
Breaking Down Osteoarthritis: Exploring Inflammatory and Mechanical Signaling Pathways
Batarfi, W. A., Yunus, M. H. M., Hamid, A. A., Maarof, M., & Rani, R. A. (2025) · Life · doi:10.3390/life15081238 · Cited by 46
Gu, S., Liang, J., Zhang, J., Liu, Z., Miao, Y., Wei, Y., Li, S., Gu, J., Cui, Y., Xiao, T., et al. (2023) · Molecules · doi:10.3390/molecules28052195 · Cited by 41
Vahabi, S. M., Bahramian, S., Esmaeili, F., Danaei, B., Kalantari, Y., Fazeli, P., Sadeghi, S., Hajizadeh, N., Assaf, C., & Etesami, I. (2024) · Cancers · doi:10.3390/cancers16050861 · Cited by 41
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
Sajjadi-Dokht, M., Mohammad, T. A. M., Rahman, H. S., Maashi, M. S., Danshina, S. D., Shomali, N., Solali, S., Marofi, F., Zeinalzadeh, E., Akbari, M., et al. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.10.009 · Cited by 41
Xie, Z., Jiang, N.-H., Lin, M., He, X., Li, B., Dong, Y., Chen, S., & Lv, G. (2023) · Molecules · doi:10.3390/molecules28217355 · Cited by 40
Peng, W., Yang, Y., Lu, H., Shi, H., Jiang, L., Liao, X., Zhao, H., Wang, W., & Liu, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117682 · Cited by 40
Ferroptosis meets inflammation: A new frontier in cancer therapy
Liu, H., Xue, H., Guo, Q., Xue, X., Yang, L., Zhao, K., & Liu, Y. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217696 · Cited by 44
Wang, T., Lin, S., Li, H., Liu, R., Liu, Z., Xu, H., Li, Q., & Kai-shun, B. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153313 · Cited by 40
Cheng, W., Wang, X., Wu, Y., Li, W., Fu, C., Zou, L., & Zhang, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116181 · Cited by 40
The molecular mechanisms underlying anti‐inflammatory effects of galangin in different diseases
Hassanein, E. H. M., El‐Maksoud, M. S. A., Ibrahim, I. M., Abd‐alhameed, E. K., Althagafy, H. S., Mohamed, N. M., & Ross, S. A. (2023) · Phytotherapy Research · doi:10.1002/ptr.7874 · Cited by 42
The role of natural products targeting macrophage polarization in sepsis-induced lung injury
Li, Y., Ai, S., Li, Y., Ye, W., Li, R., Xu, X., & Liu, Q. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01067-4 · Cited by 40
Self-citationHan, X., Hu, J., Zhao, W., Lu, H., Dai, J., & He, Q. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113064 · Cited by 39
Adipokine Signaling Pathways in Osteoarthritis
Zhang, C., Lin, Y., Yan, C. H., & Zhang, W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.865370 · Cited by 38
Functionalized extracellular vesicles of mesenchymal stem cells for regenerative medicine
Yoo, D., Jung, S. Y., Go, D., Park, J. Y., You, D. G., Jung, W., Li, Y., Ding, J., Park, J. H., & Um, W. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03300-6 · Cited by 41
Liu, C., Zhao, Q., Zhong, L. X., Li, Q., Li, R., Li, S., Li, Y., Li, N., Su, J., Dhondrup, W., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113820 · Cited by 38
Wu, Z., Cai, Z., Shi, H., Huang, X., Cai, M., Yuan, K., Huang, P., Shi, G., Yan, T., & Li, Z. (2022) · Aging · doi:10.18632/aging.204030 · Cited by 37
Song, Z., Liu, X., Zhang, W., Luo, Y., Xiao, H., Liu, Y., Dai, G., Hong, J., & Li, A. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03366-y · Cited by 41
The dual function of microglial polarization and its treatment targets in ischemic stroke
Mo, Y., Xu, W., Fu, K., Chen, H., Wen, J., Huang, Q., Guo, F., Mo, L., & Yan, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.921705 · Cited by 39
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
Collotta, D., Franchina, M. P., Carlucci, V., & Collino, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1245535 · Cited by 43
Regulation of the JAK/STAT signaling pathway in spinal cord injury: an updated review
Guo, X., Jiang, C. Q., Chen, Z., Wang, X., Hong, F., & Hao, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1276445 · Cited by 38
Kohal, R., Bisht, P., Gupta, G. D., & Verma, S. K. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107095 · Cited by 37
Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications
Shen, G., Liu, J., Wang, Y., Deng, Z., & Deng, F. (2025) · MedComm · doi:10.1002/mco2.70349 · Cited by 47
Self-citationLi, N., Li, Y., Zheng, P., & Zhan, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.755805 · Cited by 37
Zhao, Q., Bai, J., Chen, Y., Liu, X., Zhao, S., Ling, G., Jia, S., Zhai, F., & Xiang, R. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115567 · Cited by 41
Xiu, M., Wang, Y., Yang, D., Zhang, X., Dai, Y., Liu, Y., Lin, X., Li, B., & He, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1072715 · Cited by 36
Self-citationMohammadgholi, M., & Hosseinimehr, S. J. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230407104208 · Cited by 42
Rao, T., Tong, H., Li, J., Huang, J., Yin, Y., & Zhang, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155319 · Cited by 36
Golmohammadi, M., Zamanian, M. Y., Al‐Ani, A. M., Jabbar, T. L., Kareem, A. K., Aghaei, Z. H., Tahernia, H., Hjazi, A. M., Jissir, S. A.-R., & Hakimizadeh, E. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12491 · Cited by 36
Li, P., & Huang, D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1507621 · Cited by 37
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions
He, S., Zhou, Z., Cheng, M., Hao, X., Chiang, T., Wang, Y., Zhang, J., Wang, X., Ye, X., Wang, R., et al. (2025) · MedComm · doi:10.1002/mco2.70054 · Cited by 36
Self-citationWen, T.-H., Tsai, K., Wu, Y., Liao, M.-T., Lu, K., & Hu, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413310 · Cited by 38
JAK inhibition as a new treatment strategy for patients with COVID-19
Huang, J., Zhou, C., Jinniu, D., & Zhou, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115162 · Cited by 36
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Fialho, M. F. P., Brum, E. S., & Oliveira, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01160-w · Cited by 33
Current status of drugs targeting PDGF/PDGFR
Ai, J.-Y., Liu, C., Zhang, W., & Rao, G. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103989 · Cited by 36
Yan, M., Sun, Z., Zhang, S., Yang, G., Jiang, X. Y., Wang, G., Li, R., Wang, Q., & Tian, X. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110988 · Cited by 38
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia
Naji, N. S., Sathish, M., & Karantanos, T. (2024) · Cancers · doi:10.3390/cancers16233974 · Cited by 38
Research progress on pharmacokinetics, anti-inflammatory and immunomodulatory effects of kaempferol.
Li, S.-R., Wang, S.-W., Zhang, L., Ka, Y., Zhou, M.-J., Wang, Y.-W., Tang, Z., Zhang, J., Wang, W., & Liu, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114387 · Cited by 38
Self-citationKostik, M. M., Raupov, R. K., Suspitsin, E. N., Isupova, E. A., Gaidar, E. V., Gabrusskaya, T. V., Kaneva, M. A., Snegireva, L. S., Likhacheva, T. S., Mulkidzhan, R., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.820586 · Cited by 38
Bao, D., Zhuang, C., Jiao, Y., & Li, Y. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00913-w · Cited by 35
Atwa, A. M., El‐Ghafar, O. A. M. A., Hassanein, E. H. M., Mahdi, S. E., Sayed, G. A., Alruhaimi, R. S., Alqhtani, H. A., Alotaibi, M., & Mahmoud, A. M. (2022) · Pharmaceuticals · doi:10.3390/ph15101222 · Cited by 36
Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents
Lu, C., Wei, J., Gao, C., Sun, M., Dong, D., & Mu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113373 · Cited by 37
Unraveling the Gut–Liver–Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches
Aghara, H., Patel, M., Chadha, P., Parwani, K., Chaturvedi, R., & Mandal, P. (2025) · Mediators of Inflammation · doi:10.1155/mi/6733477 · Cited by 39
Chikhale, R. V., Sinha, S. K., Wanjari, M., Gurav, N. S., Ayyanar, M., Prasad, S. K., Khanal, P., Dey, Y. N., Patil, R. B., & Gurav, S. S. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10183-w · Cited by 36
Xu, Y. X., Zhang, D., Yang, H., Liu, Y., Zhang, L., Zhang, C., Chen, G., Hu, Y., Chen, J., Zhang, H., et al. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5050 · Cited by 36
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
Jain, N. K., Tailang, M., Jain, H. K., Chandrasekaran, B., Sahoo, B. M., Subramanian, A., Thangavel, N., Aldahish, A. A., Chidambaram, K., Muthumanickam, A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1135145 · Cited by 34
Sun, X., Yang, L., Sun, H. J., Sun, Y., Wei, S., Han, Y., Wang, W., Kong, L. D., & Wang, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1275974 · Cited by 33
Advances in cellular and molecular pathways of salivary gland damage in Sjögren’s syndrome
Qi, W., Tian, J., Wang, G., Yan, Y., Wang, T., Wei, Y., Wang, Z., Zhang, G., Zhang, Y., & Wang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405126 · Cited by 33
Downregulation of SETD7 promotes migration and invasion of lung cancer cells via JAK2/STAT3 pathway
Cao, L., Ren, Y., Guo, X., Wang, L., Zhang, Q., Li, X., Wu, X., Meng, Z., & Xu, K. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4523 · Cited by 31
Multi-Source Pathways of T Follicular Helper Cell Differentiation
Ma, X., Nakayamada, S., & Wang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621105 · Cited by 33
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
Caiazzo, G., Caiazzo, A., Napolitano, M., Megna, M., Potestio, L., Fornaro, L., Parisi, M., Luciano, M. A., Ruggiero, A., Testa, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082865 · Cited by 35
Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review
Zhang, Q., Wang, R., & Xu, L. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-956 · Cited by 31
Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies
Khan, F., Pandey, P., Verma, M., & Upadhyay, T. K. (2024) · Biomolecules · doi:10.3390/biom14020200 · Cited by 31
Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies
Ali, G. F., Hassanein, E. H. M., & Mohamed, W. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03164-x · Cited by 31
Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis
Yu, L., Li, S., Pu, L., Yang, C., Shi, Q., Zhao, Q., Shengbu, M., Liu, Y., Zhang, Y., & Lai, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.938915 · Cited by 31
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins
Cianciulli, A., Calvello, R., Porro, C., Lofrumento, D. D., & Panaro, M. A. (2024) · Cells · doi:10.3390/cells13060505 · Cited by 34
Convergence of sepsis-associated encephalopathy pathogenesis onto microglia
Xiao, D., Wang, X., Liang, W., Yang, Y., Du, Y., Liu, C., Xu, F., Yang, Y., Wei, M., & Yang, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06635-8 · Cited by 33
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway
Gao, A., Hu, Y., & Zhu, W. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02668-9 · Cited by 30
Wu, Y., Chen, J., Jiang, L., Wu, X., Liu, Y., Gao, C., Wu, Y., Yi, X.-Q., Su, Z., Cai, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.698219 · Cited by 30
Yang, T., Chen, X., Mei, Z., Liu, X., Feng, Z., Liao, J., Deng, Y., & Ge, J. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s328837 · Cited by 30
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis
Calabrese, L., Chiricozzi, A., SIMONE, C. D., Fossati, B., D'Amore, A., & Peris, K. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2099835 · Cited by 30
Endothelial extracellular vesicles induce acute lung injury via follistatin-like protein 1
Yuan, H., Chen, Y.-T., Li, Y., Wang, Y., Ou, Z., Li, Y., Gao, J., Deng, M.-J., Song, Y.-K., Fu, L., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2328-x · Cited by 30
Self-citationNovel insights into STAT3 in renal diseases
Yu, J.-T., Fan, S., Li, X.-Y., Hou, R., Hu, X., Wang, J.-N., Shan, R.-R., Dong, Z.-H., Xie, M.-M., Dong, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115166 · Cited by 34
Wu, Y., Wei, M., & Zhang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1200254 · Cited by 29
Wang, Z., Sun, L., Xu, Y., Liang, P., Xu, K., & Huang, J. L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04443-6 · Cited by 29
Kumar, S., Mehan, S., Khan, Z., Gupta, G. D., & Narula, A. S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03902-x · Cited by 29
Preclinical development and clinical studies of targeted JAK/STAT combined Anti-PD-1/PD-L1 therapy
Chen, M., & Wang, S.-L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111717 · Cited by 29
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Jia, J., Zhou, X. J., & Chu, Q. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04983-5 · Cited by 31
Self-citationWu, J., Gao, W., Shen, L., Chen, Y.-L., Du, S., Du, Z., Zhao, X., & Lu, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118223 · Cited by 29
Liao, Y., Xie, X., Zhang, C., Zhong, H., Shan, L., Yu, P., & Xu, L.-P. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.107747 · Cited by 29
Eshaq, A. M., Flanagan, T. W., Hassan, S.-Y., Asheikh, S. A. A., Al-Amoudi, W. A., Santourlidis, S., Hassan, S.-L., Alamodi, M. O., Bendhack, M. L., Alamodi, M. O., et al. (2024) · Cancers · doi:10.3390/cancers16152754 · Cited by 31
Immunologic role of macrophages in sepsis-induced acute liver injury
Xu, W., Hou, H., Yang, W., Tang, W., & Sun, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113492 · Cited by 32
Jing, J., Sun, J., Wu, Y., Zhang, N., Liu, C., Chen, S., Li, W., Hong, C., Xu, B., & Chen, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.770565 · Cited by 29
Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
Manna, S. L., Benedictis, I. D., & Marasco, D. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.792546 · Cited by 30
Luo, R., Wang, Y., Guo, Q., Fan, C., Jiang, G., Wang, L., Zou, M., Wang, T., Sun, Y., & Peng, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108819 · Cited by 29
Self-citationZhang, X., Han, X.-W., Jiang, Y., Wang, Y., He, X.-L., Liu, D., Huang, J., Liu, H.-H., Ye, T., Li, S.-J., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110747 · Cited by 29
Self-citationManna, S. L., Lopez‐Sanz, L., Bernal, S., Jiménez-Castilla, L., Priéto, I., Morelli, G., Gómez‐Guerrero, C., & Marasco, D. (2020) · Antioxidants · doi:10.3390/antiox9080754 · Cited by 28
Lariccia, V., Magi, S., Serfilippi, T., Toujani, M., Gratteri, S., & Amoroso, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124021 · Cited by 28
SPP1 promotes radiation resistance through JAK2 / STAT3 pathway in esophageal carcinoma
Wang, M., Sun, X., Xin, H., Wen, Z., & Cheng, Y. (2022) · Cancer Medicine · doi:10.1002/cam4.4840 · Cited by 28
Ojueromi, O. O., Oboh, G., & Ademosun, A. O. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01035-6 · Cited by 28
Al-Rawashde, F. A., Al-wajeeh, A. S., Nazari, M., Saad, H. K. M., Johan, M. F., Taib, W. R. W., Ismail, I., & Al‐Jamal, H. A. N. (2022) · Pharmaceuticals · doi:10.3390/ph15091123 · Cited by 29
Zhao, L., Han, S., & Chai, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116150 · Cited by 28
Lu, Y., Ma, Q., Yu, L., Huang, H., Liu, X., Chen, P., Ran, H., & Liu, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109693 · Cited by 28
Li, H., Wang, H., Qiao, G., Liu, Y., Zhang, F., & Pan, F. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110591 · Cited by 28
Exploration of gut microbiome and inflammation: A review on key signalling pathways
Nigam, M., Devi, K., Coutinho, H. D. M., & Mishra, A. P. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111140 · Cited by 31
Pal, R., Matada, G. S. P., Teli, G., Saha, M., & Patel, R. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107696 · Cited by 27
Yang, M., Bai, M., Zhuang, Y., Lu, S., Ge, Q., Li, H., Deng, Y. L., Wu, H., Xu, X., Niu, F., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01772 · Cited by 27
Self-citationIntermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3
Fan, S., He, J., Yang, Y., & Wang, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.817874 · Cited by 29
Gu, P., Cai, G., Yang, Y., Hu, Y., Liu, J., & Wang, D. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.038 · Cited by 27
Gu, Q., Lin, J., Lü, X., Chen, T., Yunyang, W., & Yang, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115428 · Cited by 26
Ojha, A. A., Srivastava, A., Votapka, L. W., & Amaro, R. E. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01589 · Cited by 27
Xi, Y., Zhang, X., Luo, Q.-X., Gan, H.-N., Liu, Y.-S., Shao, S., & Mao, X. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1187638 · Cited by 26
Song, T., Zhang, Y., Zhu, L., Zhang, Y., & Song, J. (2023) · Medicine · doi:10.1097/md.0000000000035890 · Cited by 27
Liu, Z., Zhao, L., Huang, L., Qin, Y., Zhang, J., Zhang, J., & Yan, Q. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.06.023 · Cited by 26
Strand, V., Kaine, J., Alten, R., Wallenstein, G. V., Diehl, A. M., Shi, H. H., Germino, R., & Murray, C. W. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02324-7 · Cited by 26
Metadata
- Authors
- Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S.
- Affiliations
- Harbin Medical University (CN)
- China Pharmaceutical University (CN)
- Southeast University (CN)
- Corresponding author
- Sun, Shiqin
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 80
- Pages
- 106210
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3001733563
- Cited by
- 1,010
- References
- 184
- Citations by year
- 2026: 125 · 2025: 229 · 2024: 224 · 2023: 195 · 2022: 160 · 2021: 56 · 2020: 20
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundamental Research Funds for the Central Universities (2018XN-25, JFWLD201904)
- National Natural Science Foundation of China (81903763)
- China Postdoctoral Science Foundation (2019M661312)
- Natural Science Foundation of Heilongjiang Province (YQ2019H005)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- JAK/STAT signaling, JAK inhibitors, STAT proteins, JAK kinases, inflammatory diseases, cancer, immune regulation, signaling crosstalk, cell proliferation and differentiation, apoptosis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immune System Diseases, Inflammation, Signal Transduction, Cytokines, Protein Kinase Inhibitors, STAT Transcription Factors, Janus Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review